OpenEvidence, chatgg for doctors, raises $200m at $6B valuation

Open evidenceused tools and nurses due to talk about medicine, announced plans to increase $ 200 million with a value of $ 6 billion, The York Times New York reportsSee rank-.

The fresh fund comes three months after the startup raised $210 million at a valuation of $3.5 billion, a testament to strong investor interest in industry-specific AI applications.

Trained in medical journals from JAAMA and New Medicine, the OpenEvidence platform helps users quickly get answers to medical knowledge that exists to treat patients. Verified medical professionals can access the OpenEvidence tool, which is supported by advertising, for free.

OPENEVidence has grown rapidly since 2022. The monthly clinical consultation response has almost doubled to 15 million since July, every time.

The round was led by Google Ventures, with participation from Sequoia Capital, Perkins Kleiner, Blackstone, Capital, Layer Management, and Craft.

TechCrunch has reached out to OpenEvidence for comment.